Back

Carbohydrate antigen 125 as a predictor of mortality and heart failure outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis

28 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Improving management in transcatheter aortic valve intervention Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Laurenzano Cintia

Bs As (Argentina)

6 More presentations in this session

Presentation thumbnail
Continuing sodium-glucose cotransporter-2 inhibitors after transcatheter aortic valve implantation improves survival and renal outcomes
Doctor Y. Chuang (Taichung, TW)
Abstract Slides
Presentation thumbnail
Impact of right atrial remodeling on mortality after transcatheter aortic valve implantation
Doctor K. Guzman Valencia (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Impact of aortic annulus size on clinical and hemodynamic outcomes of transcatheter aortic valve implantation with the navitor valve
Doctor J. Capparelli (Rome, IT)
Abstract Slides
Presentation thumbnail
Clinical yield of discharge transthoracic echocardiography in transcatheter aortic valve implantation patients from a contemporary cohort
Mr O. Ward (DK)
Abstract Slides
Presentation thumbnail
Temporal trends of TAVI waiting times in a tertiary centre: from initial implementation to contemporary practice
Doctor G. Zaburaite (Vilnius, LT)
Abstract Slides

Access the full session

Session thumbnail
Improving management in transcatheter aortic valve intervention

The Event

Event poster

ESC Congress 2026

28 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction
22 May 2022
thumbnail
Congress Presentation
Clinical outcomes of patients undergoing percutaneous coronary intervention and transcatheter aortic valve implantation versus coronary artery bypass grafting and surgical aortic valve replacement
1 September 2025
thumbnail
Congress Presentation
Tissue factor, a membrane-associated biomarker of platelet activation, predicts 5-year cardiovascular mortality in coronary artery disease patients
1 September 2025
thumbnail
Congress Presentation
Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources